Found: 15
Select item for more details and to access through your institution.
Curcumin enhances non-opsonic phagocytosis of Plasmodium falciparum through up-regulation of CD36 surface expression on monocytes/macrophages.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 8, p. 1895, doi. 10.1093/jac/dks132
- By:
- Publication type:
- Article
Indolone-N-oxide derivatives: in vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established antimalarial drugs.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Indolone-N-oxide derivatives: in vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established antimalarial drugs.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 11, p. 2566, doi. 10.1093/jac/dkr320
- By:
- Publication type:
- Article
Identification of a 1,2,4,5-Tetraoxane Antimalarial Drug-Development Candidate (RKA 182) with Superior Properties to the Semisynthetic Artemisinins.
- Published in:
- Angewandte Chemie, 2010, v. 122, n. 33, p. 5829, doi. 10.1002/ange.201001026
- By:
- Publication type:
- Article
Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 5, p. 836, doi. 10.3390/biom13050836
- By:
- Publication type:
- Article
Titelbild: Artemisone—A Highly Active Antimalarial Drug of the Artemisinin Class (Angew. Chem. 13/2006).
- Published in:
- Angewandte Chemie, 2006, v. 118, n. 13, p. 2041, doi. 10.1002/ange.200690045
- By:
- Publication type:
- Article
Artemisone—A Highly Active Antimalarial Drug of the Artemisinin ClassWork at the HKUST was funded by Bayer AG Central Research, Leverkusen, the Institute of Molecular Technology for Drug Discovery and Synthesis through the HKSAR University Grants Committee Areas of Excellence Fund, and the HKSAR Research Grants Council through the Competitive Earmarked Research Grants Scheme. The Medicines for Malaria Venture (MMV), Geneva, also provided financial support of the work at Bayer, and through Bayer at HKUST and other centers. Dr. W. Collins (Centers for Disease Control, Atlanta) supplied P. falciparum FVO strain used for the primate studies.
- Published in:
- Angewandte Chemie, 2006, v. 118, n. 13, p. 2136, doi. 10.1002/ange.200503071
- By:
- Publication type:
- Article
Highly Antimalaria-Active Artemisinin Derivatives: Biological Activity Does Not Correlate with Chemical Reactivity ( This work was supported by grants from Bayer AG (Leverkusen, Germany) and by the Government of the HKSAR University Grants Council (grant no. HKUST 6091/02P). )
- Published in:
- Angewandte Chemie, 2004, v. 116, n. 11, p. 1405, doi. 10.1002/ange.200352343
- By:
- Publication type:
- Article
Cover Picture: Artemisone—A Highly Active Antimalarial Drug of the Artemisinin Class (Angew. Chem. Int. Ed. 13/2006).
- Published in:
- Angewandte Chemie International Edition, 2006, v. 45, n. 13, p. 1989, doi. 10.1002/anie.200690045
- By:
- Publication type:
- Article
Artemisone—A Highly Active Antimalarial Drug of the Artemisinin ClassWork at the HKUST was funded by Bayer AG Central Research, Leverkusen, the Institute of Molecular Technology for Drug Discovery and Synthesis through the HKSAR University Grants Committee Areas of Excellence Fund, and the HKSAR Research Grants Council through the Competitive Earmarked Research Grants Scheme. The Medicines for Malaria Venture (MMV), Geneva, also provided financial support of the work at Bayer, and through Bayer at HKUST and other centers. Dr. W. Collins (Centers for Disease Control, Atlanta) supplied P. falciparum FVO strain used for the primate studies.
- Published in:
- Angewandte Chemie International Edition, 2006, v. 45, n. 13, p. 2082, doi. 10.1002/anie.200503071
- By:
- Publication type:
- Article
Highly Antimalaria-Active Artemisinin Derivatives: Biological Activity Does Not Correlate with Chemical Reactivity ( This work was supported by grants from Bayer AG (Leverkusen, Germany) and by the Government of the HKSAR University Grants Council (grant no. HKUST 6091/02P). )
- Published in:
- Angewandte Chemie International Edition, 2004, v. 43, n. 11, p. 1381, doi. 10.1002/anie.200352343
- By:
- Publication type:
- Article
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.
- Published in:
- Molecules, 2017, v. 22, n. 12, p. 2102, doi. 10.3390/molecules22122102
- By:
- Publication type:
- Article
Preparation of N-Sulfonyl- and N-Carbonyl-11-Azaartemisinins with Greatly Enhanced Thermal Stabilities: in vitro Antimalarial Activities.
- Published in:
- ChemMedChem, 2007, v. 2, n. 10, p. 1464, doi. 10.1002/cmdc.200700065
- By:
- Publication type:
- Article
The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria.
- Published in:
- Malaria Journal, 2011, v. 10, n. Suppl 1, p. 1, doi. 10.1186/1475-2875-10-S1-S10
- By:
- Publication type:
- Article
Identification of a 1,2,4,5-Tetraoxane Antimalarial Drug-Development Candidate (RKA 182) with Superior Properties to the Semisynthetic Artemisinins.
- Published in:
- Angewandte Chemie International Edition, 2010, v. 49, n. 33, p. 5693, doi. 10.1002/anie.201001026
- By:
- Publication type:
- Article